Search hospitals > Georgia > Gainesville
Northeast Georgia Medical Center
Claim this profileGainesville, Georgia 30501
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Fallopian Tube Cancer
254 reported clinical trials
8 medical researchers
Summary
Northeast Georgia Medical Center is a medical facility located in Gainesville, Georgia. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Fallopian Tube Cancer and other specialties. Northeast Georgia Medical Center is involved with conducting 254 clinical trials across 317 conditions. There are 8 research doctors associated with this hospital, such as Charles H. Nash, Habib Samady, MD, Pranav Kansara, MD, and Ugochukwu Egolum, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderER positive
Stage IV
PR positive
Top PIs
Charles H. NashNortheast Georgia Medical Center-Gainesville6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
20 reported clinical trials
55 drugs studied
Habib Samady, MDNortheast Georgia Medical Center5 years of reported clinical research
Studies Stroke
Studies Atherosclerosis
3 reported clinical trials
9 drugs studied
Pranav Kansara, MDNortheast Georgia Medical Center7 years of reported clinical research
Studies Heart Failure
Studies Stroke
2 reported clinical trials
2 drugs studied
Ugochukwu Egolum, MDNortheast Georgia Medical Center4 years of reported clinical research
Studies Heart Failure
2 reported clinical trials
2 drugs studied
Clinical Trials running at Northeast Georgia Medical Center
Lung Cancer
Colorectal Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Ovarian Cancer
Breast cancer
Prostate Cancer
Breast Cancer
Lymphoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Tepotinib + Ramucirumab
for Lung Cancer
This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non-small cell lung cancer that has spread from where it first started (primary site) to other places in the body (stage IV) or that has come back after a period of improvement (recurrent). Tepotinib is used in patients whose cancer has a mutated (changed) form of a gene called MET. It is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal MET protein that signals tumor cells to multiply. This helps slow or stop the spread of tumor cells. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Giving tepotinib with ramucirumab may lower the chance of the cancer from growing or spreading in patients with stage IV or recurrent non-small cell lung cancer.
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northeast Georgia Medical Center?
Northeast Georgia Medical Center is a medical facility located in Gainesville, Georgia. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer, Fallopian Tube Cancer and other specialties. Northeast Georgia Medical Center is involved with conducting 254 clinical trials across 317 conditions. There are 8 research doctors associated with this hospital, such as Charles H. Nash, Habib Samady, MD, Pranav Kansara, MD, and Ugochukwu Egolum, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.